Merz (Merz Pharma GmbH & Co. KGaA) is a privately held healthcare company headquartered in Frankfurt am Main, Germany. The company focuses on the research, development, and GMP manufacturing of pharmaceuticals and medical-aesthetic products, with operations spanning medical aesthetics and therapeutics.
Merz’s portfolio includes hyaluronic acid dermal fillers (Belotero), botulinum toxin type A for aesthetic and therapeutic indications (Xeomin/Bocouture), and calcium hydroxylapatite injectables (Radiesse). Its products serve dermatology, plastic surgery, aesthetic medicine, and neurology specialties. Merz operates a global network of development and production sites, including facilities in Germany, and distributes its products worldwide through the Merz Aesthetics and Merz Therapeutics divisions.
